BioCentury | Jul 25, 2019
Tools & Techniques

New CRISPR case to finally settle the score

...Neon Therapeutics Inc. (NASDAQ:NTGN), Cambridge, Mass. Novartis AG (NYSE:NVS), Basel, Switzerland ToolGen Inc. (KONEX:199800), Seoul, Korea University...
BioCentury | Oct 4, 2018
Tools & Techniques

No crisp upper hand in CRISPR

...Germany MPEG LA LLC, Denver, Colo. Novartis AG (NYSE:NVS), Basel, Switzerland ToolGen Inc., Seoul, South Korea University...
BioCentury | Oct 3, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: September 2018

...culture studies suggest promoting ATP5H expression could help treat therapy-resistant cancers Johns Hopkins University ; Korea University...
BioCentury | Sep 26, 2018
Distillery Therapeutics

Cancer

...Md. email: wutc@jhmi.edu CONTACT: Tae Woo Kim, Korea University, Seoul, South Korea email: twkim0421@korea.com Sandi Wong Johns Hopkins University Korea University ATP...
BioCentury | Apr 13, 2018
Targets & Mechanisms

Hello RNA

...oxygen species modulator 1 (ROMO1) Colorectal cancer Cell-based Inhibiting ROMO1 could help treat colorectal cancer. Korea University...
...the cancer cells into non-tumorigenic cells ( No. 1341 ). In addition, a group from Korea University...
...Leverkusen, Germany Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Expansion Therapeutics Inc., San Diego, Calif. Korea University...
BioCentury | Aug 31, 2017
Targets & Mechanisms

Necroptosis strikes again

...NYSE:GSK), London, U.K. Harvard University, Cambridge, Mass. Korea Institute of Science and Technology, Seoul, South Korea University...
BioCentury | Aug 9, 2017
Distillery Therapeutics

Cancer

...online July 17, 2017 doi:10.1158/0008-5472.CAN-17-0072 CONTACT: Tae Woo Kim, Korea University, Seoul, South Korea email: twkim0421@korea.ac.kr Hongjiang Li Korea University Granzyme...
BioCentury | Aug 3, 2017
Tools & Techniques

The other side of the Rubicon

...Portland, Ore. Salk Institute for Biological Studies, La Jolla, Calif. Seoul National University, Seoul, South Korea University...
BioCentury | Aug 18, 2016
Distillery Therapeutics

Therapeutics: Cullin 3 (CUL3)

...Jin, X. et al. Cell Rep.; published online July 28, 2016 doi:10.1016/j.celrep.2016.06.092 CONTACT: Hyunggee Kim, Korea University...
BioCentury | Apr 28, 2016
Finance

Public-Private Partnership Roundup

...Ohio State University, Columbus, Ohio Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Seoul National University, Seoul, South Korea University...
Items per page:
1 - 10 of 22
BioCentury | Jul 25, 2019
Tools & Techniques

New CRISPR case to finally settle the score

...Neon Therapeutics Inc. (NASDAQ:NTGN), Cambridge, Mass. Novartis AG (NYSE:NVS), Basel, Switzerland ToolGen Inc. (KONEX:199800), Seoul, Korea University...
BioCentury | Oct 4, 2018
Tools & Techniques

No crisp upper hand in CRISPR

...Germany MPEG LA LLC, Denver, Colo. Novartis AG (NYSE:NVS), Basel, Switzerland ToolGen Inc., Seoul, South Korea University...
BioCentury | Oct 3, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: September 2018

...culture studies suggest promoting ATP5H expression could help treat therapy-resistant cancers Johns Hopkins University ; Korea University...
BioCentury | Sep 26, 2018
Distillery Therapeutics

Cancer

...Md. email: wutc@jhmi.edu CONTACT: Tae Woo Kim, Korea University, Seoul, South Korea email: twkim0421@korea.com Sandi Wong Johns Hopkins University Korea University ATP...
BioCentury | Apr 13, 2018
Targets & Mechanisms

Hello RNA

...oxygen species modulator 1 (ROMO1) Colorectal cancer Cell-based Inhibiting ROMO1 could help treat colorectal cancer. Korea University...
...the cancer cells into non-tumorigenic cells ( No. 1341 ). In addition, a group from Korea University...
...Leverkusen, Germany Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Expansion Therapeutics Inc., San Diego, Calif. Korea University...
BioCentury | Aug 31, 2017
Targets & Mechanisms

Necroptosis strikes again

...NYSE:GSK), London, U.K. Harvard University, Cambridge, Mass. Korea Institute of Science and Technology, Seoul, South Korea University...
BioCentury | Aug 9, 2017
Distillery Therapeutics

Cancer

...online July 17, 2017 doi:10.1158/0008-5472.CAN-17-0072 CONTACT: Tae Woo Kim, Korea University, Seoul, South Korea email: twkim0421@korea.ac.kr Hongjiang Li Korea University Granzyme...
BioCentury | Aug 3, 2017
Tools & Techniques

The other side of the Rubicon

...Portland, Ore. Salk Institute for Biological Studies, La Jolla, Calif. Seoul National University, Seoul, South Korea University...
BioCentury | Aug 18, 2016
Distillery Therapeutics

Therapeutics: Cullin 3 (CUL3)

...Jin, X. et al. Cell Rep.; published online July 28, 2016 doi:10.1016/j.celrep.2016.06.092 CONTACT: Hyunggee Kim, Korea University...
BioCentury | Apr 28, 2016
Finance

Public-Private Partnership Roundup

...Ohio State University, Columbus, Ohio Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Seoul National University, Seoul, South Korea University...
Items per page:
1 - 10 of 22